Skip to content

Jones Day

Corporate/M&A: International

Band 4JapanAsia-Pacific 2022 View ranking table
chambers review
department information
chambers review
department information

Chambers Review

Chambers Research is conducted by 200 Research Analysts, across 200 jurisdictions and provides nearly 6,000 rankings tables. Annually we collect hundreds of thousands of responses from clients, the majority via in-depth interview. Learn more about our methodology.

What the team is known for

Jones Day holds a solid track record in handling outbound acquisitions and global transactions involving assets in Japan. Additionally advises multinationals, investment management firms and private equity houses regarding inbound investments. Active across a range of sectors including pharmaceuticals, natural resources, insurance and technology. Leverages its global network to provide seamless advice on cross-border transactions and offers further assistance with aspects such as antitrust and labour law. Key clients include Sumitovant Biopharma, Bally's Corporation, and JERA Power International BV.


A client praises the Jones Day team's service, commercial awareness and value as "excellent on all fronts," explaining the law firm is "efficient and thorough without over-servicing."

A further client states: "Jones Day is one of the top international law firms and very reliable. They're speedy, reliable and know how our corporation thinks."

Work highlights

Jones Day advised Sumitovant Biopharma on its USD217 million acquisition of all outstanding shares in Urovant Sciences, making Urovant a wholly owned subsidiary.

Notable practitioners

Greg Salathé is a key contact for clients.

Department Information

info This Department has not yet supplied any additional information.
Corporate/M&A: International

Jones Day


The Okura Prestige Tower

2-10-4 Toranomon






View Firm Profile